ResearcherJiangnan UniversityNo recent work listed

Xu Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8425-036X; OpenAlex author ID A5100385737. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 2 papers

Papers 2

A 70‑RNA model based on SVR and RFE for predicting the pancreatic cancer clinical prognosis. Co-author DOI 10.1016/j.ymeth.2022.02.011 ↗
Contributions and prognostic performances of m7G RNA regulators in pancreatic adenocarcinoma. Co-author DOI 10.1097/cm9.0000000000002179 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yanrui Ding · 1 shared paper, 2022 · strength 0.22
- Paper A 70‑RNA model based on SVR and RFE for predicting the pancreatic cancer clinical prognosis. DOI 10.1016/j.ymeth.2022.02.011 ↗
Jing Yang · 1 shared paper, 2022 · strength 0.22
- Paper A 70‑RNA model based on SVR and RFE for predicting the pancreatic cancer clinical prognosis. DOI 10.1016/j.ymeth.2022.02.011 ↗
Qihang Yuan · 1 shared paper, 2022 · strength 0.20
- Paper Contributions and prognostic performances of m7G RNA regulators in pancreatic adenocarcinoma. DOI 10.1097/cm9.0000000000002179 ↗
Dong Shang · 1 shared paper, 2022 · strength 0.20
- Paper Contributions and prognostic performances of m7G RNA regulators in pancreatic adenocarcinoma. DOI 10.1097/cm9.0000000000002179 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.